Viewing StudyNCT06332274



Ignite Creation Date: 2024-05-06 @ 8:18 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06332274
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-16
First Post: 2024-02-29

Brief Title: tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
Sponsor: Gustave Roussy Cancer Campus Grand Paris
Organization: Gustave Roussy Cancer Campus Grand Paris

Organization Data

Organization: Gustave Roussy Cancer Campus Grand Paris
Class: OTHER
Study ID: 2023-503316-33-00
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Gustave Roussy Cancer Campus Grand Paris
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
BeiGene INDUSTRY
C2i Genomics INDUSTRY